Trials that use: Interim analysis / alpha spending
New to this method? Read the tutorial →
11,819 results
- Study of Clofarabine in Patients With Recurrent or Refractory Langerhans Cell Histiocytosis and LCH-related Disorders: Complete Statistical AnalysisIndependent statistical analysis of Study of Clofarabine in Patients With Recurrent or Refractory Langerhans Cell Histiocytosis and LCH-related Disorders: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Study of Combined Decompressive Spine Radiosurgery and Pembrolizumab: Complete Statistical AnalysisIndependent statistical analysis of Study of Combined Decompressive Spine Radiosurgery and Pembrolizumab: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05204290).
- Study of Concurrent Paclitaxel and Radiation: Correlation of Tumor Profiles With Pathologic Response: Complete Statistical AnalysisIndependent statistical analysis of Study of Concurrent Paclitaxel and Radiation: Correlation of Tumor Profiles With Pathologic Response: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Study of Copanlisib in Hepatic or Renal Impairment: Complete Statistical AnalysisIndependent statistical analysis of Study of Copanlisib in Hepatic or Renal Impairment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03172884).
- Study Of CP-751,871 In Combination With Sunitinib In Patients With Advanced Solid Tumors: Complete Statistical AnalysisIndependent statistical analysis of Study Of CP-751,871 In Combination With Sunitinib In Patients With Advanced Solid Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Study of CTX-471 as a Monotherapy or in Combination With Pembrolizumab in Patients Post PD-1/PD-L1 Inhibitors in Metastatic or Locally Advanced Malignancies: Complete Statistical AnalysisIndependent statistical analysis of Study of CTX-471 as a Monotherapy or in Combination With Pembrolizumab in Patients Post PD-1/PD-L1 Inhibitors in Metastatic or Locally Advanced Malignancies: primary endpoint results, effect estimate with…
- Study of DA-9501 In Pediatric Subjects In The Intensive Care Unit: Complete Statistical AnalysisIndependent statistical analysis of Study of DA-9501 In Pediatric Subjects In The Intensive Care Unit: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Study of Daclatasvir (BMS-790052) and Simeprevir (TMC435) in Patients With Genotype 1 Chronic Hepatitis C Virus: Complete Statistical AnalysisIndependent statistical analysis of Study of Daclatasvir (BMS-790052) and Simeprevir (TMC435) in Patients With Genotype 1 Chronic Hepatitis C Virus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Study of Dalantercept and Axitinib in Patients With Advanced Renal Cell Carcinoma: Complete Statistical AnalysisIndependent statistical analysis of Study of Dalantercept and Axitinib in Patients With Advanced Renal Cell Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Study of Dalantercept in Patients With Squamous Cell Carcinoma of the Head and Neck: Complete Statistical AnalysisIndependent statistical analysis of Study of Dalantercept in Patients With Squamous Cell Carcinoma of the Head and Neck: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study of Danicopan in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH): Complete Statistical AnalysisIndependent statistical analysis of Study of Danicopan in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03053102).
- Study of Daptomycin in Subjects Undergoing Surgery for Osteomyelitis Associated With an Infected Prosthetic Caused by Staphylococci: Complete Statistical AnalysisIndependent statistical analysis of Study of Daptomycin in Subjects Undergoing Surgery for Osteomyelitis Associated With an Infected Prosthetic Caused by Staphylococci: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Study of DAXDILIMAB for the Treatment of Moderate-to-Severe Alopecia Areata: Complete Statistical AnalysisIndependent statistical analysis of Study of DAXDILIMAB for the Treatment of Moderate-to-Severe Alopecia Areata: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05368103).
- Study of Decitabine for Treatment of Older Patients With Acute Myeloid Leukemia (AML): Complete Statistical AnalysisIndependent statistical analysis of Study of Decitabine for Treatment of Older Patients With Acute Myeloid Leukemia (AML): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Study of Diclofenac Capsules to Treat Osteoarthritis Pain: Complete Statistical AnalysisIndependent statistical analysis of Study of Diclofenac Capsules to Treat Osteoarthritis Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01461369).
- Study of Donepezil in Female Breast Cancer Survivors With Cognitive Dysfunction: Complete Statistical AnalysisIndependent statistical analysis of Study of Donepezil in Female Breast Cancer Survivors With Cognitive Dysfunction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Study of Dose Adjustment From Levothyroxine to a New Levothyroxine Sodium Test Formulation: Complete Statistical AnalysisIndependent statistical analysis of Study of Dose Adjustment From Levothyroxine to a New Levothyroxine Sodium Test Formulation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Study of Dose Escalation of Liposomal Amikacin for Inhalation (ARIKAYCE™) – Extension Phase: Complete Statistical AnalysisIndependent statistical analysis of Study of Dose Escalation of Liposomal Amikacin for Inhalation (ARIKAYCE™) - Extension Phase: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Study of Dose Escalation Versus no Dose Escalation of Imatinib in Metastatic Gastrointestinal Stromal Tumors (GIST) Patients: Complete Statistical AnalysisIndependent statistical analysis of Study of Dose Escalation Versus no Dose Escalation of Imatinib in Metastatic Gastrointestinal Stromal Tumors (GIST) Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Study of Dovitinib and Biomarkers in Advanced Non-Small Cell Lung Cancer or Advanced Colorectal Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study of Dovitinib and Biomarkers in Advanced Non-Small Cell Lung Cancer or Advanced Colorectal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared With PENTAXIM™ and ENGERIX B® PEDIATRICO in Argentinean Infants: Complete Statistical AnalysisIndependent statistical analysis of Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared With PENTAXIM™ and ENGERIX B® PEDIATRICO in Argentinean Infants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Study of Dupilumab Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis: Complete Statistical AnalysisIndependent statistical analysis of Study of Dupilumab Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Study of Dupilumab for the Treatment of Patients With Prurigo Nodularis, Inadequately Controlled on Topical Prescription Therapies or When Those Therapies Are Not Advisable (LIBERTY-PN PRIME): Complete Statistical AnalysisIndependent statistical analysis of Study of Dupilumab for the Treatment of Patients With Prurigo Nodularis, Inadequately Controlled on Topical Prescription Therapies or When Those Therapies Are Not Advisable (LIBERTY-PN PRIME): primary endpoint…
- Study of Efavaleukin Alfa in Healthy Chinese, Japanese, and Caucasian Participants: Complete Statistical AnalysisIndependent statistical analysis of Study of Efavaleukin Alfa in Healthy Chinese, Japanese, and Caucasian Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Study of Effectiveness and Safety of SD-101 in Participants With Epidermolysis Bullosa: Complete Statistical AnalysisIndependent statistical analysis of Study of Effectiveness and Safety of SD-101 in Participants With Epidermolysis Bullosa: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Study of Efficacy and Safety of Canakinumab in Japanese Patients With SJIA: Complete Statistical AnalysisIndependent statistical analysis of Study of Efficacy and Safety of Canakinumab in Japanese Patients With SJIA: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma: Complete Statistical AnalysisIndependent statistical analysis of Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Previously Treated Patients With Metastatic, Radio-active Iodine Refractory BRAF V600E Mutation Positive Differentiated Thyroid Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Previously Treated Patients With Metastatic, Radio-active Iodine Refractory BRAF V600E Mutation Positive Differentiated Thyroid Cancer: primary…
- Study of Efficacy and Safety of Drugs BCD-033 and Rebif for Treatment of Patients With Multiple Sclerosis: Complete Statistical AnalysisIndependent statistical analysis of Study of Efficacy and Safety of Drugs BCD-033 and Rebif for Treatment of Patients With Multiple Sclerosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Study of Efficacy and Safety of LOU064 in Inadequately Controlled Asthma Patients: Complete Statistical AnalysisIndependent statistical analysis of Study of Efficacy and Safety of LOU064 in Inadequately Controlled Asthma Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Study of Efficacy and Safety of NIS793 in Combination With Standard of Care (SOC) Chemotherapy in First-line Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC) – daNIS-2: Complete Statistical AnalysisIndependent statistical analysis of Study of Efficacy and Safety of NIS793 in Combination With Standard of Care (SOC) Chemotherapy in First-line Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC) - daNIS-2: primary endpoint results, effect…
- Study of Efficacy and Safety of Omalizumab in Severe Japanese Cedar Pollinosis Adult and Adolescent Patients: Complete Statistical AnalysisIndependent statistical analysis of Study of Efficacy and Safety of Omalizumab in Severe Japanese Cedar Pollinosis Adult and Adolescent Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Study of Efficacy and Safety of QAW039 in Patients With Severe Asthma Inadequately Controlled With Standard of Care Asthma Treatment.: Complete Statistical AnalysisIndependent statistical analysis of Study of Efficacy and Safety of QAW039 in Patients With Severe Asthma Inadequately Controlled With Standard of Care Asthma Treatment.: primary endpoint results, effect estimate with confidence interval,…
- Study of Efficacy and Safety of Reinfusion of Tisagenlecleucel in Pediatric and Young Adult Patients With Acute Lymphoblastic Leukemia (ALL): Complete Statistical AnalysisIndependent statistical analysis of Study of Efficacy and Safety of Reinfusion of Tisagenlecleucel in Pediatric and Young Adult Patients With Acute Lymphoblastic Leukemia (ALL): primary endpoint results, effect estimate with confidence interval,…
- Study of Efficacy and Safety of Xolair® (Omalizumab) in Chinese Patients With Chronic Spontaneous Urticaria: Complete Statistical AnalysisIndependent statistical analysis of Study of Efficacy and Safety of Xolair® (Omalizumab) in Chinese Patients With Chronic Spontaneous Urticaria: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Study of Efficacy, Safety and Tolerability of AIN457 in Patients With Active Overuse Tendinopathy: Complete Statistical AnalysisIndependent statistical analysis of Study of Efficacy, Safety and Tolerability of AIN457 in Patients With Active Overuse Tendinopathy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study of Efficacy, Safety, and Tolerability of LYS006, in Patients With Mild to Moderate Ulcerative Colitis: Complete Statistical AnalysisIndependent statistical analysis of Study of Efficacy, Safety, and Tolerability of LYS006, in Patients With Mild to Moderate Ulcerative Colitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Study of Enzalutamide (Formerly MDV3100) as a Neoadjuvant Therapy for Patients Undergoing Prostatectomy for Localized Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study of Enzalutamide (Formerly MDV3100) as a Neoadjuvant Therapy for Patients Undergoing Prostatectomy for Localized Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Study of Enzalutamide in Patients With Castration-resistant Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study of Enzalutamide in Patients With Castration-resistant Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01942837).
- Study of Epidural Steroid Injection (ESI) Versus Minimally Invasive Lumbar Decompression (Mild®) in Patients With Symptomatic Lumbar Central Canal Stenosis: Complete Statistical AnalysisIndependent statistical analysis of Study of Epidural Steroid Injection (ESI) Versus Minimally Invasive Lumbar Decompression (Mild®) in Patients With Symptomatic Lumbar Central Canal Stenosis: primary endpoint results, effect estimate with confidence interval,…
- Study of Eribulin Mesylate in Combination With PEGylated Recombinant Human Hyaluronidase (PEGPH20) Versus Eribulin Mesylate Alone in Subjects With Human Epidermal Growth Factor Receptor 2 (HER2)-Negative, High-Hyaluronan (HA) Metastatic Breast Cancer (MBC): Complete Statistical AnalysisIndependent statistical analysis of Study of Eribulin Mesylate in Combination With PEGylated Recombinant Human Hyaluronidase (PEGPH20) Versus Eribulin Mesylate Alone in Subjects With Human Epidermal Growth Factor Receptor 2 (HER2)-Negative, High-Hyaluronan (HA)…
- Study of Evacetrapib (LY2484595) and Warfarin in Healthy Participants: Complete Statistical AnalysisIndependent statistical analysis of Study of Evacetrapib (LY2484595) and Warfarin in Healthy Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02161731).
- Study of Fampridine-SR Tablets in Multiple Sclerosis Patients: Complete Statistical AnalysisIndependent statistical analysis of Study of Fampridine-SR Tablets in Multiple Sclerosis Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00483652).
- Study of Favezelimab (MK-4280) as Monotherapy and in Combination With Pembrolizumab (MK-3475) With or Without Chemotherapy or Lenvatinib (MK-7902) AND Favezelimab/Pembrolizumab (MK-4280A) as Monotherapy in Adults With Advanced Solid Tumors (MK-4280-001): Complete Statistical AnalysisIndependent statistical analysis of Study of Favezelimab (MK-4280) as Monotherapy and in Combination With Pembrolizumab (MK-3475) With or Without Chemotherapy or Lenvatinib (MK-7902) AND Favezelimab/Pembrolizumab (MK-4280A) as Monotherapy in Adults With Advanced…
- Study of Fc-Optimized Anti-CD19 Antibody (MOR00208) to Treat B-cell Acute Lymphoblastic Leukemia(B-ALL): Complete Statistical AnalysisIndependent statistical analysis of Study of Fc-Optimized Anti-CD19 Antibody (MOR00208) to Treat B-cell Acute Lymphoblastic Leukemia(B-ALL): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Study of Fixed-Dose Combinations of Trabodenoson and Latanoprost in Adults With OHT or POAG: Complete Statistical AnalysisIndependent statistical analysis of Study of Fixed-Dose Combinations of Trabodenoson and Latanoprost in Adults With OHT or POAG: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study of Fluticasone Propionate MDPI Compared With Fluticasone/Salmeterol MDPI in Adolescent and Adult Patients With Persistent Asthma: Complete Statistical AnalysisIndependent statistical analysis of Study of Fluticasone Propionate MDPI Compared With Fluticasone/Salmeterol MDPI in Adolescent and Adult Patients With Persistent Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Study of Fluzone® Quadrivalent, Fluzone® Intradermal Quadrivalent, and Fluzone® High-Dose, Influenza Vaccines in Adults: Complete Statistical AnalysisIndependent statistical analysis of Study of Fluzone® Quadrivalent, Fluzone® Intradermal Quadrivalent, and Fluzone® High-Dose, Influenza Vaccines in Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study of Fruquintinib in Patients With Metastatic Colorectal Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study of Fruquintinib in Patients With Metastatic Colorectal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02196688).
- Study of FX006 vs Normal Saline in Patients With Osteoarthritis of the Knee: Complete Statistical AnalysisIndependent statistical analysis of Study of FX006 vs Normal Saline in Patients With Osteoarthritis of the Knee: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…